Enovis (ENOV)

Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System ('CBS'), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates.

Company profile

Ticker

ENOV

Exchange

NYSE

Website

www.colfaxcorp.com

CEO

Matthew Trerotola

Incorporated

Delaware

Location

Delaware

Fiscal year end

Dec 31

Sector

Manufacturing > Pump and Pumping Equipment Manufacturing

Industry (SIC)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet • Steris • Intuitive Surgical • Avanos Medical • Edwards Lifesciences • Invacare • MSA Safety • Align Technology • Wright Medical • Surgalign ...

Former names

Colfax CORP

SEC CIK

0001420800

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Agridzaar Limited • Airgare Limited • Arc Machines GmbH • Canadian Cylinder Company Ltd. • CAST Limited • CAST Resources Limited • Cefar-Compex Medical AB • Central Mining Finance Limited • Charter Central Finance Limited • Charter Central Services Limited ...

IRS number

541887631

ENOV stock data

1M 1Y 5Y

News

From Benzinga Pro

Stocks That Hit 52-Week Lows On Thursday

30 Jun 22

On Thursday, 588 stocks hit new 52-week lows.

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

28 Jun 22

Upgrades

Argus Research Initiates Coverage On Enovis with Hold Rating

28 Jun 22

Argus Research analyst John Eade initiates coverage on Enovis (NYSE:ENOV) with a Hold rating.

Loop Capital Assumes Enovis at Buy, Announces Price Target of $68

27 Jun 22

Stocks That Hit 52-Week Lows On Wednesday

22 Jun 22

Press releases

From Benzinga Pro

Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™

15 Jun 22

A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both tri-malleolar and intra-articular fracture patterns DJO® is now part

Enovis to Participate in the Goldman Sachs Global Healthcare Conference

6 Jun 22

Wilmington, DE, June 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, will participate in the Goldman

Enovis Announces First Quarter 2022 Adjusted Stand Alone Results

10 May 22

Wilmington, DE, May 10, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE:ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced its adjusted stand-alone

Enovis Schedules First Quarter 2022 Earnings Release and Conference Call

14 Apr 22

Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation

5 Apr 22

Analyst ratings and price targets

Last 3 months

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

10 May 22

2 Jul 22

31 Dec 22

Financial summary

Financial statements Chart ENOV financial data

Quarter (USD)	Apr 22	Dec 21	Oct 21	Jul 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Oct 21	Jul 21	Apr 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)		661.5M	661.5M	661.5M	661.5M	661.5M
Cash burn (monthly)		58.45M	(no burn)	(no burn)	4.81M	(no burn)
Cash used (since last report)		179.24M	n/a	n/a	14.74M	n/a
Cash remaining		482.27M	n/a	n/a	646.76M	n/a
Runway (months of cash)		8.3	n/a	n/a	134.5	n/a

Beta Read what these cash burn values mean

Financial data from Enovis earnings reports.

Recent insider trades

ENOV insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Jun 22	Perfall A Clayton	Common stock, par value $0.001	Grant	Acquire A	No	No	0	432	0	31,073
30 Jun 22	Lalor Angela S	Common stock, par value $0.001	Grant	Acquire A	No	No	0	319	0	2,363
30 Jun 22	Wienbar Sharon L	Common stock, par value $0.001	Grant	Acquire A	No	No	0	410	0	18,879
7 Jun 22	Vinnakota Rajiv	Common stock, par value $.001	Grant	Acquire A	No	No	0	1,648	0	11,901
7 Jun 22	Vinnakota Rajiv	Director stock option Common stock, par value $.001	Grant	Acquire A	No	No	67.28	3,464	233.06K	3,464
7 Jun 22	Liam Kelly	Common stock, par value $.001	Grant	Acquire A	No	No	0	1,648	0	6,793
7 Jun 22	Liam Kelly	Director stock option Common stock, par value $.001	Grant	Acquire A	No	No	67.28	3,464	233.06K	3,464

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

ENOV institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	250	3	+8233.3%
Opened positions	248	1	+24700.0%
Closed positions	1	270	-99.6%
Increased positions	1	1	–
Reduced positions	1	1	–

13F shares	Current	Prev Q	Change
Total value	5.01B	1.11B	+349.1%
Total shares	125.66M	24.25M	+418.1%
Total puts	296.3K	0	NEW
Total calls	276.5K	0	NEW
Total put/call ratio	1.1	–	–

Largest owners	Shares	Value	Change
TROW T. Rowe Price	18.36M	$730.73M	-0.7%
Vanguard	12.62M	$502.23M	NEW
BLK Blackrock	10.88M	$432.99M	NEW
Cooke & Bieler	7.01M	$278.96M	NEW
Dimensional Fund Advisors	6.31M	$251.27M	+9.8%
Diamond Hill Capital Management	6.15M	$244.68M	NEW
Durable Capital Partners	4.24M	$168.75M	NEW
Southpoint Capital Advisors	4.1M	$163.14M	NEW
Cardinal Capital Management	3.66M	$145.58M	NEW
STT State Street	3.59M	$142.66M	NEW

Largest transactions	Shares	Bought/sold	Change
Vanguard	12.62M	+12.62M	NEW
BLK Blackrock	10.88M	+10.88M	NEW
Cooke & Bieler	7.01M	+7.01M	NEW
Diamond Hill Capital Management	6.15M	+6.15M	NEW
Durable Capital Partners	4.24M	+4.24M	NEW
Southpoint Capital Advisors	4.1M	+4.1M	NEW
Cardinal Capital Management	3.66M	+3.66M	NEW
STT State Street	3.59M	+3.59M	NEW
American Century Companies	3.14M	+3.14M	NEW
Wellington Management	3.01M	+3.01M	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Management Discussion

Gross profit increased in the first quarter of 2022 compared with the prior year period due to a $24.5 million increase in our Fabrication Technology segment and a $34.6 million increase in our Medical Technology segment. The Gross profit increase was primarily attributable to business acquisition-related increases, favorable sales mix, and improved volumes. Increased Gross profit in our Medical Technology segment was also due to acquisition growth primarily in Reconstructive product lines. Improved Gross profit in both segments was partially offset by increased supply chain and logistic costs. Gross profit margin was impacted by the same drivers as Gross profit, but decreased slightly due to inflation-related customer pricing and cost increases in our Fabrication Technology segment.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: central, commencing, concurrently, conduct, conducted, construction, correct, daily, disposition, EBS, EGX, energy, enhance, ENOV, escalation, Excellence, expired, facilitate, hand, heighten, hiring, identity, imposed, inability, incentive, incorrect, indemnification, indemnify, indemnity, Kingdom, license, LIFO, longer, military, noncash, overnight, past, political, pursue, rapidly, rebranded, refinanced, relationship, rely, renewable, repaid, repay, restated, retention, retroactively, Russia, simple, site, slight, SOFR, SONIA, split, stake, sterling, sufficient, susceptible, swingline, symbol, taxation, tied, transferred, transition, transportation, Ukraine, unaffiliated, uncover, violated

Removed: acceptable, addressing, adjacent, adjusting, agent, Aid, approach, approval, area, arithmetic, Arsenal, assert, assumption, ASU, attention, attracting, Bank, borrower, broad, calculation, call, CBS, challenge, Chase, collateral, combined, complex, concentrated, consecutive, consulting, contemplated, continued, conversion, correlation, court, cultivating, decline, deductible, delay, deliver, diluted, diminish, diminished, discretionary, diversification, diversion, domestic, earlier, EBITDA, effectuate, entity, equally, establishing, evolving, excluded, executing, expansion, fixation, focused, foreseen, formulate, frame, fulfillment, furloughing, Goodwill, group, growing, guaranteed, guidance, holiday, home, implant, increasing, independently, India, intended, intention, intraperiod, jointly, JPMorgan, jurisdiction, likelihood, location, mandatory, marine, meeting, memory, mining, motivating, newly, nickel, NiTiNOL, observed, obtain, obtaining, occurring, oil, operate, patented, pendency, personal, placement, Plating, polymer, portfolio, postponement, postretirement, power, prepayment, prevent, pro, professional, proforma, proposed, prospective, provision, putting, qualify, rank, rata, receipt, receive, recognize, reducing, registered, regulatory, Relief, removed, residual, restricted, restricting, Retirement, sale, satisfactorily, satisfactory, scheduled, separated, separating, September, shape, Simplifying, smaller, speed, spine, sponsor, springing, steel, stimulation, structure, structured, successful, superelastic, support, suspending, sustain, syndication, targeted, targeting, temporarily, temporary, thereto, threshold, tier, timeline, titanium, today, Topic, treated, treatment, unforeseen, universe, unsubordinated, vulnerable, weakening, wind, withdrawal

From filing 10-Q 2022 Q1

Financial reports

View all